ZymeQuest, a manufacturer of enzyme products, is planning to expand into the market for blood and transfusion devices with its platelet-refrigeration technology. The company is hoping to secure an estimated $30 million within the next few months to begin human trials of the technology by 2010. ZymeQuest is also working on an automated blood component processor that would enable the faster and more efficient separation of plasma from red blood cells.

Related Summaries